Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Articles
Conference Highlights ADA
Artificial Pancreas Passes Test in Patients with Type 1 Diabetes
Read More
Conference Highlights ADA
Intensive versus Standard Blood Pressure Control of No Benefit in Quality of Life for Patients with Type 2 Diabetes
Read More
Conference Highlights ADA
Medical Food Improves Symptoms of Diabetic Neuropathy
Read More
Conference Highlights ADA
HbA1c Screening Fails to Identify Many Patients with Diabetes and Prediabetes
Read More
Conference Highlights ADA
Education, Counseling Associated with Improved Clinical Outcomes in Type 2 Diabetes
Read More
Conference Highlights ADA
Ultra-Long-Acting Insulin Degludec Noninferior to Insulin Glargine with Less Hypoglycemia in Type 1 and Type 2 Diabetes
Read More
Conference Highlights ADA
Treatment Satisfaction Highest for Diabetic Patients Taking Only Oral Medications
Read More
Conference Highlights ADA
Once-Weekly GLP-1 Agonist Noninferior to Metformin in Treatment-Naïve Patients with Type 2 Diabetes
Read More
Conference Highlights ADA
Adding Saxagliptin to Metformin Improves Glycemic Control Over Uptitrating Metformin Dose
Read More
Conference Highlights ADA
Initiation of Therapy with a Sulfonylurea Increased Risk of Cardiovascular Events versus Metformin in Older Adults with Type 2 Diabetes
Read More
210
211
212
213
214
215
216
Page 213 of 246
Results 2121 - 2130 of 2457